| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |